Common use of New In-Licensed Isis Product-Specific Patents; Isis Manufacturing and Analytical Patents Clause in Contracts

New In-Licensed Isis Product-Specific Patents; Isis Manufacturing and Analytical Patents. If after the Effective Date, Isis obtains Third Party Patent Rights necessary or useful to Develop, Manufacture or Commercialize a Product that would have been considered an Isis Product-Specific Patent had Isis Controlled such Patent Rights on the Effective Date, to the extent Controlled by Isis, Isis will include such Third Party Patent Rights in the license granted to Biogen Idec under Section 4.1.1(a) or Section 4.1.1(b) (as applicable) if Biogen Idec agrees in writing to pay Isis as [***].

Appears in 1 contract

Samples: License Agreement (Isis Pharmaceuticals Inc)

AutoNDA by SimpleDocs

New In-Licensed Isis Product-Specific Patents; Isis Manufacturing and Analytical Patents. If after the Effective Date, Isis obtains Third Party Patent Rights necessary or useful to Develop, Manufacture or Commercialize a Product that would have been considered an Isis Product-Specific Patent had Isis Controlled such Patent Rights on the Effective Date, to the extent Controlled by Isis, Isis will include such Third Party Patent Rights in the license granted to Biogen Idec under Section 4.1.1(a) or Section 4.1.1(b) (as applicable) 4.1.1 if Biogen Idec agrees in writing to pay Isis as [***].

Appears in 1 contract

Samples: License Agreement (Isis Pharmaceuticals Inc)

New In-Licensed Isis Product-Specific Patents; Isis Manufacturing and Analytical Patents. If If, after the Effective Date, Isis obtains Third Party Patent Rights necessary or useful to Develop, Manufacture or Commercialize a Product that would have been considered an Isis Product-Specific Patent had Isis Controlled such Patent Rights on the Effective Date, to the extent Controlled by Isis, Isis will include such Third Party Patent Rights in the license granted to Biogen Idec under Section 4.1.1(a) or Section 4.1.1(b) (as applicable) 4.1.1 if Biogen Idec agrees in writing to pay Isis as [***].

Appears in 1 contract

Samples: Option and License Agreement (Isis Pharmaceuticals Inc)

AutoNDA by SimpleDocs

New In-Licensed Isis Product-Specific Patents; Isis Manufacturing and Analytical Patents. If If, after the Effective Date, Isis obtains Third Party Patent Rights necessary or useful to Develop, Manufacture or Commercialize a Product that would have been considered an Isis Product-Specific Patent had Isis Controlled such Patent Rights on the Effective Date, to the extent Controlled by Isis, Isis will include such Third Party Patent Rights in the license granted to Biogen Idec under Section 4.1.1(a) or Section 4.1.1(b) (as applicable) 4.1.1 if Biogen Idec agrees in writing to pay Isis as [***].

Appears in 1 contract

Samples: Development, Option and License Agreement (Isis Pharmaceuticals Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.